Documents

EBITDA nearly doubled year-over-year, with the Olin merger set to drive $300M in synergies.

$12B+ merger forms a global chemicals leader with $400M+ synergies and strong integration.

$12B+ merger forms a chemicals leader with $400M+ synergies and balanced governance.

Margin recovery underway as pricing outpaces costs, but demand and supply risks persist.

Board elections, compensation, and auditor ratified; independent chair proposal rejected.

Cost cuts, strong cash flow, and early recovery signs set a cautiously optimistic 2026 outlook.

Cost savings, dividend cut, and cash focus drive resilience amid global market headwinds.

Advanced materials rebounded, but polyurethanes faced weak demand and pricing amid trade volatility.

Tariffs and trade volatility disrupt Q1, but North American MDI poised for recovery.

2024 saw Huntsman post a net loss, lower EBITDA, and execute key portfolio changes.